###
中国临床研究英文版:2024,37(6):968-971
本文二维码信息
码上扫一扫!
药品和医疗器械上市后研究概述
(1. 中国整合医学发展战略研究院,陕西 西安 710032;2. 山西医科大学,山西 太原 030001;3.上海明品整合医学研究院,上海 201600;4. 北京大学药学院,北京 100191;5.3. 上海明品整合医学研究院,上海 201600;6.5. 空军军医大学西京医院,陕西 西安 710032)
Overview of post-marketing research on medicines and medical devices
摘要
本文已被:浏览 33次   下载 46
Received:September 15, 2023   Published Online:June 20, 2024
中文摘要: 药品和医疗器械上市后研究是产品全生命周期管理的重要环节。本文在文献调研和专家咨询基础上,提出药械产品上市后研究的概念体系,即什么是上市后研究(What)、为什么要开展上市后研究(Why)、谁开展上市后研究(Who)、如何开展上市后研究(How)、上市后研究的目的和目标(Objective)的3WHO框架。
Abstract:Post-marketing research on medicines and medical devices is an important aspect of product lifecycle management. Based on literature research and expert consultation, this article proposes a conceptual system for post-marketing research of pharmaceutical and medical devices, which includes a 3WHO framework of what is post-marketing research(What), why should post-marketing research(Why) be conducted, who should conduct post-marketing research(Who), how to conduct post-marketing research(How), and the objective of post-marketing research (Objective).
文章编号:     中图分类号:R97 R197.39    文献标志码:A
基金项目:中国工程院战略研究与咨询项目(2022-HZ-10)
引用文本:


Scan with WeChat

Scan with WeChat